# Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Continuous Glucose Monitor Data Management System
> **Food and Drug Administration** · Final order. · Published 2019-10-29 · Effective 2019-10-29 · 84 FR 57816
## Document
- **Document number:** 2019-23471
- **Category:** fda-device
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 84 FR 57816
- **CFR reference:** 21 CFR 862
- **Publication date:** 2019-10-29
- **Effective date:** 2019-10-29
- **HHS docket:** Docket No. FDA-2019-N-2484
## Abstract

The Food and Drug Administration (FDA or we) is classifying the continuous glucose monitor data management system into class I (general controls). We are taking this action because we have determined that classifying the device into class I (general controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2019/10/29/2019-23471/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-continuous)
---
*AI Analytics · CC0 1.0*